Glucose, foetal growth, and pregnancy

Gestational Diabetes: Origins, Complications, and Treatment

Volumn , Issue , 2014, Pages 3-32

  Chen, Xinhua ^a   Scholl, Theresa O ^a  

^a UMDNJ School of Osteopathic Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85007324240     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b16474     Document Type: Chapter

References (130)

1. Di Cianni, G., Miccoli, R., Volpe, L., Lencioni, C., and Del Prato, S. 2003. Intermediate Metabolism in Normal Pregnancy and in Gestational Diabetes. Diabetes Metab Res Rev 19:259-70.
2. Catalano, P.M., Huston, L., Amini, S.B., and Kalhan, S.C. 1999. Longitudinal Changes in Glucose Metabolism during Pregnancy in Obese Women with Normal Glucose Tolerance and Gestational Diabetes Mellitus. Am J Obstet Gynecol 180:903-16.
3. Catalano, P.M., Tyzbir, E.D., Wolfe, R.R., Calles, J., Roman, N.M., Amini, S.B., and Sims, E.A. 1993. Carbohydrate Metabolism during Pregnancy in Control Subjects and Women with Gestational Diabetes. Am J Physiol 264:E60-67.
4. Sivan, E., Homko, C.J., Whittaker, P.G., Reece, E.A., Chen, X., and Boden, G. 1998. Free Fatty Acids and Insulin Resistance during Pregnancy. J Clin Endocrinol Metab 83:2338-42.
5. Catalano, P.M., and Hauguel-De Mouzon, S. 2011. Is It Time to Revisit the Pedersen Hypothesis in the Face of the Obesity Epidemic? Am J Obstet Gynecol 204:479-87.
6. Sivan, E., Homko, C.J., Chen, X., Reece, E.A., and Boden, G. 1999. Effect of Insulin on Fat Metabolism during and after Normal Pregnancy. Diabetes 48:834-38.
7. Kalhan, S.C., D’Angelo, L.J., Savin, S.M., and Adam, P.A. 1979. Glucose Production in Pregnant Women at Term Gestation. Sources of Glucose for Human Fetus. J Clin Invest 63:388-94.
8. Kalhan, S., Rossi, K., Gruca, L., Burkett, E., and O’Brien, A. 1997. Glucose Turnover and Gluconeogenesis in Human Pregnancy. J Clin Invest 100:1775-81.
9. Catalano, P.M., Kirwan, J.P., Haugel-de Mouzon, S., and King, J. 2003. Gestational Diabetes and Insulin Resistance: Role in Short-and Long-Term Implications for Mother and Fetus. J Nutr 133:1674S-83S.
10. Getahun, D., Nath, C., Ananth, C.V., Chavez, M.R., and Smulian, J.C. 2008. Gestational Diabetes in the United States: Temporal Trends 1989 through 2004. Am J Obstet Gynecol 198:525 e1-5.
11. Ferrara, A. 2007. Increasing Prevalence of Gestational Diabetes Mellitus: A Public Health Perspective. Diabetes Care 30(Suppl 2):S141-46.
12. Boden, G., and Shulman, G.I. 2002. Free Fatty Acids in Obesity and Type 2 Diabetes: Defining Their Role in the Development of Insulin Resistance and Beta-Cell Dysfunction. Eur J Clin Invest 32:14-23.
13. Catalano, P.M. 2010. Obesity, Insulin Resistance, and Pregnancy Outcome. Reproduction 140:365-71.
14. Xiang, A.H., Peters, R.K., Trigo, E., Kjos, S.L., Lee, W.P., and Buchanan, T.A. 1999. Multiple Metabolic Defects during Late Pregnancy in Women at High Risk for Type 2 Diabetes. Diabetes 48:848-54.
15. Homko, C., Sivan, E., Chen, X., Reece, E.A., and Boden, G. 2001. Insulin Secretion during and after Pregnancy in Patients with Gestational Diabetes Mellitus. J Clin Endocrinol Metab 86:568-73.
16. Barbour, L.A., McCurdy, C.E., Hernandez, T.L., Kirwan, J.P., Catalano, P.M., and Friedman, J.E. 2007. Cellular Mechanisms for Insulin Resistance in Normal Pregnancy and Gestational Diabetes. Diabetes Care 30:S112-19. A comprehensive review on cellular mechanisms of insulin resistance in normal pregnancy and GDM.
17. Brelje, T.C., Scharp, D.W., Lacy, P.E., Ogren, L., Talamantes, F., Robertson, M., Friesen, H.G., and Sorenson, R.L. 1993. Effect of Homologous Placental Lactogens, Prolactins, and Growth Hormones on Islet B-Cell Division and Insulin Secretion in Rat, Mouse, and Human Islets: Implication for Placental Lactogen Regulation of Islet Function during Pregnancy. Endocrinology 132:879-87.
18. Beck, P., and Daughaday, W.H. 1967. Human Placental Lactogen: Studies of Its Acute Metabolic Effects and Disposition in Normal Man. J Clin Invest 46:103-10.
19. Ryan, E.A., and Enns, L. 1988. Role of Gestational Hormones in the Induction of Insulin Resistance. J Clin Endocrinol Metab 67:341-47.
20. Richardson, A.C., and Carpenter, M.W. 2007. Inflammatory Mediators in Gestational Diabetes Mellitus. Obstet Gynecol Clin North Am 34:213-24.
21. Calleja-Agius, J., Muttukrishna, S., and Jauniaux, E. 2012. The Role of Tumor Necrosis Factor-Receptors in Pregnancy with Normal and Adverse Outcome. Int J Interferon Cytokine Mediator Res 4:1-15.
22. Hauguel-de Mouzon, S., and Guerre-Millo, M. 2006. The Placenta Cytokine Network and Inflammatory Signals. Placenta 27:794-98. A review focused on the placental cytokine network and the cross talk between inflammation and metabolism pathways in pregnancy complicated by obesity or diabetes.
23. Radaelli, T., Uvena-Celebrezze, J., Minium, J., Huston-Presley, L., Catalano, P., and Hauguel-de Mouzon, S. 2006. Maternal Interleukin-6: Marker of Fetal Growth and Adiposity. J Soc Gynecol Invest 13:53-57. An original paper showing a strong association between increased foetal adiposity and maternal cytokine IL-6.
24. Briana, D.D., and Malamitsi-Puchner, A. 2010. The Role of Adipocytokines in Fetal Growth. Ann N Y Acad Sci 1205:82-87.
25. Lappas, M., Permezel, M., and Rice, G.E. 2004. Release of Proinflammatory Cytokines and 8-Isoprostane from Placenta, Adipose Tissue, and Skeletal Muscle from Normal Pregnant Women and Women with Gestational Diabetes Mellitus. J Clin Endocrinol Metab 89:5627-33.
26. Kahn, S.E., Zinman, B., Haffner, S.M., O’Neill, M.C., Kravitz, B.G., Yu, D., Freed, M.I., Herman, W.H., Holman, R.R., Jones, N.P., Lachin, J.M., Viberti, G.C., and ADOPT Study Group. 2006. Obesity Is a Major Determinant of the Association of C-Reactive Protein Levels and the Metabolic Syndrome in Type 2 Diabetes. Diabetes 55:2357-64.
27. Kriketos, A.D., Greenfield, J.R., Peake, P.W., Furler, S.M., Denyer, G.S., Charlesworth, J.A., and Campbell, L.V. 2004. Inflammation, Insulin Resistance, and Adiposity: A Study of First-Degree Relatives of Type 2 Diabetic Subjects. Diabetes Care 27:2033-40.
28. Retnakaran, R., Hanley, A.J., Raif, N., Connelly, P.W., Sermer, M., and Zinman, B. 2003. C-Reactive Protein and Gestational Diabetes: The Central Role of Maternal Obesity. J Clin Endocrinol Metab 88:3507-12.
29. Wolf, M., Sandler, L., Hsu, K., Vossen-Smirnakis, K., Ecker, J.L., and Thadhani, R. 2003. First-Trimester C-Reactive Protein and Subsequent Gestational Diabetes. Diabetes Care 26:819-24.
30. Chen, X., Scholl, T.O., and Stein, T.P. 2006. Association of Elevated Serum Ferritin Levels and the Risk of Gestational Diabetes Mellitus in Pregnant Women: The Camden Study. Diabetes Care 29:1077-82.
31. Qiu, C., Sorensen, T.K., Luthy, D.A., and Williams, M.A. 2004. A Prospective Study of Maternal Serum C-Reactive Protein (CRP) Concentrations and Risk of Gestational Diabetes Mellitus. Paediatr Perinat Epidemiol 18:377-84.
32. Income, Earnings, and Poverty Data from the 2007 American Community Survey (online). 2008. Available from http:www.census.gov/prod/2008pubs/acs-09.pdf.
33. Chen, X., Scholl, T.O., Leskiw, M., Savaille, J., and Stein, T.P. 2010. Differences in Maternal Circulating Fatty Acid Composition and Dietary Fat Intake in Women with Gestational Diabetes Mellitus or Mild Gestational Hyperglycemia. Diabetes Care 33:2049-54. Original paper that indicates the presence of elevated serum free fatty acid concentrations and composition in both GDM and gestational hyperglycaemia is less severe than overt GDM in multiethnic minority pregnant women.
34. Scholl, T.O., and Chen, X. 2009. Increased Inflammatory Response in Women with Mild Gestational Hyperglycemia. Paper presented at the 69th American Diabetes Association Scientific Sessions, New Orleans, LA.
35. Krakoff, J., Funahashi, T., Stehouwer, C.D., Schalkwijk, C.G., Tanaka, S., Matsuzawa, Y., Kobes, S., Tataranni, P.A., Hanson, R.L., Knowler, W.C., and Lindsay, R.S. 2003. Inflammatory Markers, Adiponectin, and Risk of Type 2 Diabetes in the Pima Indian. Diabetes Care 26:1745-51.
36. Tan, K.C., Xu, A., Chow, W.S., Lam, M.C., Ai, V.H., Tam, S.C., and Lam, K.S. 2004. Hypoadiponectinemia Is Associated with Impaired Endothelium-Dependent Vasodilation. J Clin Endocrinol Metab 89:765-69.
37. Duncan, B.B., Schmidt, M.I., Pankow, J.S., Bang, H., Couper, D., Ballantyne, C.M., Hoogeveen, R.C., and Heiss, G. 2004. Adiponectin and the Development of Type 2 Diabetes: The Atherosclerosis Risk in Communities Study. Diabetes 53:2473-78.
38. Williams, M.A., Qiu, C., Muy-Rivera, M., Vadachkoria, S., Song, T., and Luthy, D.A. 2004. Plasma Adiponectin Concentrations in Early Pregnancy and Subsequent Risk of Gestational Diabetes Mellitus. J Clin Endocrinol Metab 89:2306-11.
39. Ranheim, T., Haugen, F., Staff, A.C., Braekke, K., Harsem, N.K., and Drevon, C.A. 2004. Adiponectin Is Reduced in Gestational Diabetes Mellitus in Normal Weight Women. Acta Obstet Gynecol Scand 83:341-47.
40. Tsai, P.J., Yu, C.H., Hsu, S.P., Lee, Y.H., Huang, I.T., Ho, S.C., and Chu, C.H. 2005. Maternal Plasma Adiponectin Concentrations at 24 to 31 Weeks of Gestation: Negative Association with Gestational Diabetes Mellitus. Nutrition 21:1095-99.
41. Chen, X., Scholl, T.O., and Stein, T.P. 2012. Hypoadiponectinemia during Pregnancy: Association with Risk of Varying Degrees of Gestational Hyperglycemia and with Maternal Ethnicity. J Diabetes Mellitus 2:196-202.
42. Shulman, G.I. 2000. Cellular Mechanisms of Insulin Resistance. J Clin Invest 106:171-76. A comprehensive review on recent advances in understanding of cellular mechanisms of human insulin resistance and the mechanisms of free fatty acid-induced insulin resistance.
43. Yamashita, H., Shao, J. and Friedman, J.E. 2000. Physiologic and Molecular Alterations in Carbohydrate Metabolism during Pregnancy and Gestational Diabetes Mellitus. Clin Obstet Gynecol 43:87-98.
44. Buchanan, T.A., Xiang, A., Kjos, S.L., and Watanabe, R. 2007. What Is Gestational Diabetes? Diabetes Care 30:S105-11.
45. Shao, J., Catalano, P.M., Yamashita, H., Ishizuka, T., and Friedman, J.E. 2000. Vanadate Enhances but Does Not Normalize Glucose Transport and Insulin Receptor Phosphorylation in Skeletal Muscle from Obese Women with Gestational Diabetes Mellitus. Am J Obstet Gynecol 183:1263-70.
46. Tomazic, M., Janez, A., Sketelj, A., Kocijancic, A., Eckel, J., and Sharma, P.M. 2002. Comparison of Alterations in Insulin Signalling Pathway in Adipocytes from Type II Diabetic Pregnant Women and Women with Gestational Diabetes Mellitus. Diabetologia 45:502-8.
47. Shah, P., Vella, A., Basu, A., Basu, R., Adkins, A., Schwenk, W.F., Johnson, C.M., Nair, K.S., Jensen, M.D., and Rizza, R.A. 2003. Elevated Free Fatty Acids Impair Glucose Metabolism in Women: Decreased Stimulation of Muscle Glucose Uptake and Suppression of Splanchnic Glucose Production during Combined Hyperinsulinemia and Hyperglycemia. Diabetes 52:38-42.
48. King, J.C. 2006. Maternal Obesity, Metabolism, and Pregnancy Outcomes. Annu Rev Nutr 26:271-91.
49. Randle, P.J., Garland, P.B., Hales, C.N., and Newsholme, E.A. 1963. The Glucose Fatty-Acid Cycle. Its Role in Insulin Sensitivity and the Metabolic Disturbances of Diabetes Mellitus. Lancet 1:785-89.
50. McLachlan, K.A., Boston, R., and Alford, F.P. 2005. Impaired Non-Esterified Fatty Acid Suppression to Intravenous Glucose during Late Pregnancy Persists Postpartum in Gestational Diabetes: A Dominant Role for Decreased Insulin Secretion Rather Than Insulin Resistance. Diabetologia 48:1373-79.
51. Corkey, B.E. 2012. Banting Lecture 2011: Hyperinsulinemia: Cause or Consequence? Diabetes 61:4-13.
52. Chen, X., and Scholl, T.O. 2005. Oxidative Stress: Changes in Pregnancy and with Gestational Diabetes Mellitus. Curr Diabetes Rep 5:282-88.
53. Toescu, V., Nuttall, S.L., Martin, U., Nightingale, P., Kendall, M.J., Brydon, P., and Dunne, F. 2004. Changes in Plasma Lipids and Markers of Oxidative Stress in Normal Pregnancy and Pregnancies Complicated by Diabetes. Clin Sci (London) 106:93-98.
54. Chen, X., Scholl, T.O., Leskiw, M.J., Donaldson, M.R., and Stein, T.P. 2003. Association of Glutathione Peroxidase Activity with Insulin Resistance and Dietary Fat Intake during Normal Pregnancy. J Clin Endocrinol Metab 88:5963-68.
55. Pi, J., Bai, Y., Zhang, Q., Wong, V., Floering, L.M., Daniel, K., Reece, J.M., Deeney, J.T., Andersen, M.E., Corkey, B.E., and Collins, S. 2007. Reactive Oxygen Species as a Signal in Glucose-Stimulated Insulin Secretion. Diabetes 56:1783-91.
56. Ervin, R.B. 2009. Prevalence of Metabolic Syndrome among Adults 20 Years of Age and over, by Sex, Age, Race and Ethnicity, and Body Mass Index: United States, 2003-2006. Natl Health Stat Report 13:1-7.
57. Cossrow, N., and Falkner, B. 2004. Race/Ethnic Issues in Obesity and Obesity-Related Comorbidities. J Clin Endocrinol Metab 89:2590-94.
58. Ku, C.Y., Gower, B.A., Hunter, G.R., and Goran, M.I. 2000. Racial Differences in Insulin Secretion and Sensitivity in Prepubertal Children: Role of Physical Fitness and Physical Activity. Obes Res 8:506-15.
59. Chen, X., and Scholl, T.O. 2002. Ethnic Differences in C-Peptide/Insulin/Glucose Dynamics in Young Pregnant Women. J Clin Endocrinol Metab 87:4642-46.
60. Desoye, G., and Hauguel-de Mouzon, S. 2007. The Human Placenta in Gestational Diabetes Mellitus. The Insulin and Cytokine Network. Diabetes Care 30:S120-26.
61. Hay, W.W., Jr. 2006. Placental-Fetal Glucose Exchange and Fetal Glucose Metabolism. Trans Am Clin Climatol Assoc 117:321-39.
62. Beaudoin, A.R. 1983. The Effect of Aminothiadiazole on Glycogenesis and Glycogenolysis in Fetal and Neonatal Rat Liver. Teratology 28:369-74.
63. Ballard, F.J., and Oliver, I.T. 1965. Carbohydrate Metabolism in Liver from Foetal and Neonatal Sheep. Biochem J 95:191-200.
64. Hay, W.W., Jr. 2006. Recent Observations on the Regulation of Fetal Metabolism by Glucose. J Physiol 572:17-24.
65. Jansson, T., and Powell, T.L. 2000. Placental Nutrient Transfer and Fetal Growth. Nutrition 16:500-2.
66. Bauer, M.K., Harding, J.E., Bassett, N.S., Breier, B.H., Oliver, M.H., Gallaher, B.H., Evans, P.C., Woodall, S.M., and Gluckman, P.D. 1998. Fetal Growth and Placental Function. Mol Cell Endocrinol 140:115-20.
67. Holmes, R., Montemagno, R., Jones, J., Preece, M., Rodeck, C., and Soothill, P. 1997. Fetal and Maternal Plasma Insulin-Like Growth Factors and Binding Proteins in Pregnancies with Appropriate or Retarded Fetal Growth. Early Hum Dev 49:7-17.
68. Hill, D.J., Petrik, J., and Arany, E. 1998. Growth Factors and the Regulation of Fetal Growth. Diabetes Care 21(Suppl 2):B60-69.
69. Higgins, M., and McAuliffe, F. 2010. A Review of Maternal and Fetal Growth Factors in Diabetic Pregnancy. Curr Diabetes Rev 6:116-25.
70. Lacroix, M.C., Guibourdenche, J., Frendo, J.L., Muller, F., and Evain-Brion, D. 2002. Human Placental Growth Hormone-A Review. Placenta 23:S87-94.
71. Handwerger, S., and Freemark, M. 2000. The Roles of Placental Growth Hormone and Placental Lactogen in the Regulation of Human Fetal Growth and Development. J Pediatr Endocrinol Metab 13:343-56.
72. Barbour, L.A., Shao, J., Qiao, L., Pulawa, L.K., Jensen, D.R., Bartke, A., Garrity, M., Draznin, B., and Friedman, J.E. 2002. Human Placental Growth Hormone Causes Severe Insulin Resistance in Transgenic Mice. Am J Obstet Gynecol 186:512-17.
73. Haig, D. 2008. Placental Growth Hormone-Related Proteins and Prolactin-Related Proteins. Placenta 29:S36-41.
74. Boyne, M.S., Thame, M., Bennett, F.I., Osmond, C., Miell, J.P., and Forrester, T.E. 2003. The Relationship among Circulating Insulin-Like Growth Factor (IGF)-I, IGF-Binding Proteins-1 and -2, and Birth Anthropometry: A Prospective Study. J Clin Endocrinol Metab 88:1687-91.
75. Pratipanawatr, T., Pratipanawatr, W., Rosen, C., Berria, R., Bajaj, M., Cusi, K., Mandarino, L., Kashyap, S., Belfort, R., and DeFronzo, R.A. 2002. Effect of IGF-I on FFA and Glucose Metabolism in Control and Type 2 Diabetic Subjects. Am J Physiol Endocrinol Metab 282:E1360-68.
76. Clemmons, D.R. 2004. The Relative Roles of Growth Hormone and IGF-1 in Controlling Insulin Sensitivity. J Clin Invest 113:25-27.
77. Jensen, E.C., Harding, J.E., Bauer, M.K., and Gluckman, P.D. 1999. Metabolic Effects of Igf-I in the Growth Retarded Fetal Sheep. J Endocrinol 161:485-94.
78. Bauer, M.K., Breier, B.B., Bloomfield, F.H., Jensen, E.C., Gluckman, P.D., and Harding, J.E. 2003. Chronic Pulsatile Infusion of Growth Hormone to Growth-Restricted Fetal Sheep Increases Circulating Fetal Insulin-Like Growth Factor-I Levels but Not Fetal Growth. J Endocrinol 177:83-92.
79. Wauters, M., Considine, R.V., and Van Gaal, L.F. 2000. Human Leptin: From an Adipocyte Hormone to an Endocrine Mediator. Eur J Endocrinol 143:293-311.
80. Forhead, A.J., and Fowden, A.L. 2009. The Hungry Fetus? Role of Leptin as a Nutritional Signal before Birth. J Physiol 587:1145-52.
81. Zhang, J., and Bowes, W.A., Jr. 1995. Birth-Weight-for-Gestational-Age Patterns by Race, Sex, and Parity in the United States Population. Obstet Gynecol 86:200-8.
82. Brenner, W.E., Edelman, D.A., and Hendricks, C.H. 1976. A Standard of Fetal Growth for the United States of America. Am J Obstet Gynecol 126:555-64.
83. Mello, G., Parretti, E., Mecacci, F., Lucchetti, R., Lagazio, C., Pratesi, M., and Scarselli, G. 1997. Risk Factors for Fetal Macrosomia: The Importance of a Positive Oral Glucose Challenge Test. Eur J Endocrinol 137:27-33.
84. Ostlund, I., Hanson, U., Björklund, A., Hjertberg, R., Eva, N., Nordlander, E., Swahn, M.L., and Wager, J. 2003. Maternal and Fetal Outcomes if Gestational Impaired Glucose Tolerance Is Not Treated. Diabetes Care 26:2107-11.
85. Bo, S., Menato, G., Gallo, M.L., Bardelli, C., Lezo, A., Signorile, A., Gambino, R., Cassader, M., Massobrio, M., and Pagano, G. 2004. Mild Gestational Hyperglycemia, the Metabolic Syndrome and Adverse Neonatal Outcomes. Acta Obstet Gynecol Scand 83:335-40.
86. Gruendhammer, M., Brezinka, C., and Lechleitner, M. 2003. The Number of Abnormal Plasma Glucose Values in the Oral Glucose Tolerance Test and the Feto-Maternal Outcome of Pregnancy. Eur J Obstet Gynecol Reprod Biol 108:131-36.
87. Ricart, W., López, J., Mozas, J., Pericot, A., Sancho, M.A., González, N., Balsells, M., Luna, R., Cortázar, A., Navarro, P., Ramírez, O., Flández, B., Pallardo, L.F., Hernández, A., Ampudia, J., Fernández-Real, J.M., Corcoy, R., and Spanish Group for the Study of the Impact of Carpenter and Coustan GDM Thresholds. 2005. Potential Impact of American Diabetes Association (2000) Criteria for Diagnosis of Gestational Diabetes Mellitus in Spain. Diabetologia 48:1135-41.
88. Ray, J.G., Vermeulen, M.J., Shapiro, J.L., and Kenshole, A.B. 2001. Maternal and Neonatal Outcomes in Pregestational and Gestational Diabetes Mellitus, and the Influence of Maternal Obesity and Weight Gain: The Deposit Study. Diabetes Endocrine Pregnancy Outcome Study in Toronto. QJM 94:347-56.
89. Ehrenberg, H.M., Mercer, B.M., and Catalano, P.M. 2004. The Influence of Obesity and Diabetes on the Prevalence of Macrosomia. Am J Obstet Gynecol 191:964-68.
90. Catalano, P.M., Thomas, A., Huston-Presley, L., and Amini, S.B. 2007. Phenotype of Infants of Mothers with Gestational Diabetes. Diabetes Care 30:S156-60.
91. Hattersley, A.T. 2006. Beyond the Beta Cell in Diabetes. Nat Genet 38:12-13.
92. Pedersen, J. 1954. Weight and Length at Birth of Infants of Diabetic Mothers. Acta Endocrinol (Copenh) 16:330-42.
93. Ogonowski, J., Miazgowski, T., Czeszyńska, M.B., Jaskot, B., Kuczyńska, M., and Celewicz, Z. 2008. Factors Influencing Risk of Macrosomia in Women with Gestational Diabetes Mellitus Undergoing Intensive Diabetic Care. Diabetes Res Clin Pract 80:405-10.
94. Murphy, H.R., Rayman, G., Lewis, K., Kelly, S., Johal, B., Duffield, K., Fowler, D., Campbell, P.J., and Temple, R.C. 2008. Effectiveness of Continuous Glucose Monitoring in Pregnant Women with Diabetes: Randomised Clinical Trial. BMJ 337:a1680.
95. Scholl, T.O., Sowers, M., Chen, X., and Lenders, C. 2001. Maternal Glucose Concentration Influences Fetal Growth, Gestation, and Pregnancy Complications. Am J Epidemiol 154:514-20.
96. Scholl, T.O., Chen, X., Khoo, C.S., and Lenders, C. 2004. The Dietary Glycemic Index during Pregnancy: Influence on Infant Birth Weight, Fetal Growth, and Biomarkers of Carbohydrate Metabolism. Am J Epidemiol 159:467-74.
97. Chen, X., Scholl, T.O., Steer, R.A. and Stein, T.P. 2011. Gestational Hyperglycemia, Excessive Pregnancy Weight Gain and Risk of Fetal Overgrowth. In Gestational Diabetes, ed. M. Radenkovic, chap. 13. InTech open-access publisher.
98. Chen, X, and Scholl, T.O. 2008. Mild Maternal Hyperglycemia Increases Risk of Fetal Overgrowth in Minority Pregnant Women: Camden Study. Paper presented at the 68th American Diabetes Association Scientific Sessions, San Francisco, CA.
99. Catalano, P.M., McIntyre, H.D., Cruickshank, J.K., McCance, D.R., Dyer, A.R., Metzger, B.E., Lowe, L.P., Trimble, E.R., Coustan, D.R., Hadden, D.R., Persson, B., Hod, M., and Oats, J.J.; for the HAPO Study Cooperative Research Group. 2012. The Hyperglycemia and Adverse Pregnancy Outcome Study: Associations of GDM and Obesity with Pregnancy Outcomes. Diabetes Care 35:780-86. An original paper demonstrating that both maternal GDM and obesity are independently associated with adverse pregnancy outcomes in the HAPO study.
100. HAPO Study Cooperative Research Group. 2010. Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: Associations with Maternal Body Mass Index. BJOG 117:575-84.
101. Jones, H.N., Woollett, L.A., Barbour, N., Prasad, P.D., Powell, T.L., and Jansson, T. 2009. High-Fat Diet before and during Pregnancy Causes Marked Up-Regulation of Placental Nutrient Transport and Fetal Overgrowth in C57/BL6 Mice. FASEB J 23:271-78.
102. Oken, E., Kleinman, K.P., Belfort, M.B., Hammitt, J.K., and Gillman, M.W. 2009. Associations of Gestational Weight Gain with Short-and Longer-Term Maternal and Child Health Outcomes. Am J Epidemiol 170:173-80.
103. Kiel, D.W., Dodson, E.A., Artal, R., Boehmer, T.K., and Leet, T.L. 2007. Gestational Weight Gain and Pregnancy Outcomes in Obese Women: How Much Is Enough? Obstet Gynecol 110:752-58.
104. DeVader, S.R., Neeley, H.L., Myles, T.D., and Leet, T.L. 2007. Evaluation of Gestational Weight Gain Guidelines for Women with Normal Prepregnancy Body Mass Index. Obstet Gynecol 110:745-51.
105. Institute of Medicine. 2009. Weight Gain during Pregnancy: Reexamining the Guidelines. Washington, DC: National Academies Press. Available from http://www.nap.edu/catalog/12584.html.
106. Paoloni-Giacobino, A. 2007. Epigenetics in Reproductive Medicine. Pediatr Res 61:51R-57R.
107. Pinney, S.E., and Simmons, R.A. 2012. Metabolic Programming, Epigenetics, and Gestational Diabetes Mellitus. Curr Diabetes Rep 12:67-74.
108. Fernández-Morera, J.L., Rodríguez-Rodero, S., Menéndez-Torre, E., and Fraga, M.F. 2010. The Possible Role of Epigenetics in Gestational Diabetes: Cause, Consequence, or Both. Obstet Gynecol Int, article 605163.
109. Cooney, C.A., Dave, A.A. and Wolff, G.L. 2002. Maternal Methyl Supplements in Mice Affect Epigenetic Variation and DNA Methylation of Offspring. J Nutr 132:2393S-400S.
110. Lillycrop, K.A., Phillips, E.S., Jackson, A.A., Hanson, M.A., and Burdge, G.C. 2005. Dietary Protein Restriction of Pregnant Rats Induces and Folic Acid Supplementation Prevents Epigenetic Modification of Hepatic Gene Expression in the Offspring. J Nutr 135:1382-86.
111. Heijmans, B.T., Tobi, E.W., Stein, A.D., Putter, H., Blauw, G.J., Susser, E.S., Slagboom, P.E., and Lumey, L.H. 2008. Persistent Epigenetic Differences Associated with Prenatal Exposure to Famine in Humans. Proc Natl Acad Sci U S A 105:17046-49.
112. Gicquel, C., El-Osta, A., and Le Bouc, Y. 2008. Epigenetic Regulation and Fetal Programming. Best Pract Res Clin Endocrinol Metab 22:1-16.
113. Gluckman, P.D., and Hanson, M.A. 2008. Developmental and Epigenetic Pathways to Obesity: An Evolutionary-Developmental Perspective. Int J Obes 32:S62-71.
114. Yajnik, C.S. 2010. Fetal Programming of Diabetes: Still So Much to Learn! Diabetes Care 33:1146-48.
115. Catalano, P.M., Presley, L., Minium, J., and Hauguel-de Mouzon, S. 2009. Fetuses of Obese Mothers Develop Insulin Resistance In Utero. Diabetes Care 32:1076-80.
116. Langer, O., Yogev, Y., Most, O., and Xenakis, E.M. 2005. Gestational Diabetes: The Consequences of Not Treating. Am J Obstet Gynecol 192:989-97.
117. Retnakaran, R., Zinman, B., Connelly, P.W., Sermer, M., and Hanley, A.J. 2006. Impaired Glucose Tolerance of Pregnancy Is a Heterogeneous Metabolic Disorder as Defined by the Glycemic Response to the Oral Glucose Tolerance Test. Diabetes Care 29:57-62.
118. Sermer, M., Naylor, C.D., Gare, D.J., Kenshole, A.B., Ritchie, J.W.K., Farine, D., Cohen, H.R., McArthur, K., Holzapfel, S., Biringer, A., Chen, E., and Toronto Tri-Hospital Gestational Diabetes Investigators. 1995. Impact of Increasing Carbohydrate Intolerance on Maternal-Fetal Outcomes in 3637 Women without Gestational Diabetes. The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol 173:146-56.
119. Roberts, R.N., Moohan, J.M., Foo, R.L., Harley, J.M., Traub, A.I., and Hadden, D.R. 1993. Fetal Outcome in Mothers with Impaired Glucose Tolerance in Pregnancy. Diabet Med 10:438-43.
120. World Health Organisation. 1999. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Available from http://whqlibdoc.who.int/hq/1999/who_ncd_ncs_99.2.pdf.
121. Dabelea, D., Snell-Bergeon, J.K., Hartsfield, C.L., Bischoff, K.J., Hamman, R.F., McDuffie, R.S., and Kaiser Permanente of Colorado GDM Screening Program. 2005. Increasing Prevalence of Gestational Diabetes Mellitus (GDM) over Time and by Birth Cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 28:579-84.
122. King, H. 1998. Epidemiology of Glucose Intolerance and Gestational Diabetes in Women of Childbearing Age. Diabetes Care 21:B9-13.
123. Sacks, D.A., Hadden, D.R., Maresh, M., Deerochanawong, C., Dyer, A.R., Metzger, B.E., Lowe, L.P., Coustan, D.R., Hod, M., Oats, J.J., Persson, B., Trimble, E.R., and HAPO Study Cooperative Research Group. 2012. Frequency of Gestational Diabetes Mellitus at Collaborating Centers Based on IADPSG Consensus Panel-Recommended Criteria: The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 35:526-28.
124. England, L.J., Dietz, P.M., Njoroge, T., Callaghan, W.M., Bruce, C., Buus, R.M., and Williamson, D.F. 2009. Preventing Type 2 Diabetes: Public Health Implications for Women with a History of Gestational Diabetes Mellitus. Am J Obstet Gynecol 200:365 e1-e8.
125. Pettitt, D.J., Baird, H.R., Aleck, K.A., Bennett, P.H., and Knowler, W.C. 1983. Excessive Obesity in Offspring of Pima Indian Women with Diabetes during Pregnancy. N Engl J Med 308:242-45.
126. Clausen, T.D., Mathiesen, E.R., Hansen, T., Pedersen, O., Jensen, D.M., Lauenborg, J., and Damm, P. 2008. High Prevalence of Type 2 Diabetes and Pre-Diabetes in Adult Offspring of Women with Gestational Diabetes Mellitus or Type 1 Diabetes: The Role of Intrauterine Hyperglycemia. Diabetes Care 31:340-46.
127. Han, S., Crowther, C.A., and Middleton, P. 2012. Interventions for Pregnant Women with Hyperglycaemia Not Meeting Gestational Diabetes and Type 2 Diabetes Diagnostic Criteria. Cochrane Database Syst Rev 1:CD009037.
128. HAPO Study Cooperative Research Group, Metzger, B.E., Lowe, L.P., Dyer, A.R., Trimble, E.R., Chaovarindr, U., Coustan, D.R., Hadden, D.R., McCance, D.R., Hod, M., McIntyre, H.D., Oats, J.J., Persson, B., Rogers, M.S., and Sacks, D.A. 2008. Hyperglycemia and Adverse Pregnancy Outcomes. N Engl J Med 358:1991-2002. An original paper demonstrating strong and continuous associations between adverse pregnancy outcomes and various degrees of maternal glucose intolerance less severe than that in overt GDM in the HAPO study.
129. HAPO Study Cooperative Research Group. 2009. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: Associations with Neonatal Anthropometrics. Diabetes 58:453-59.
130. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger, B.E., Gabbe, S.G., Persson, B., Buchanan, T.A., Catalano, P.A., Damm, P., Dyer, A.R., Leiva, A., Hod, M., Kitzmiler, J.L., Lowe, L.P., McIntyre, H.D., Oats, J.J., Omori, Y., and Schmidt, M.I. 2010. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. Diabetes Care 33:676-82.